Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Gallium-68 Labeled Iron Oxide Nanoparticles Coated with 2,3-Dicarboxypropane-1,1-diphosphonic Acid as a Potential PET/MR Imaging Agent: A Proof-of-Concept Study.

Karageorgou MA, Vranješ-Djurić S, Radović M, Lyberopoulou A, Antić B, Rouchota M, Gazouli M, Loudos G, Xanthopoulos S, Sideratou Z, Stamopoulos D, Bouziotis P, Tsoukalas C.

Contrast Media Mol Imaging. 2017 Dec 28;2017:6951240. doi: 10.1155/2017/6951240. eCollection 2017.

2.

Enhancer of rudimentary homologue interacts with scaffold attachment factor B at the nuclear matrix to regulate SR protein phosphorylation.

Drakouli S, Lyberopoulou A, Papathanassiou M, Mylonis I, Georgatsou E.

FEBS J. 2017 Aug;284(15):2482-2500. doi: 10.1111/febs.14141. Epub 2017 Jul 8.

3.

Identification of Methylation Profiles of Cancer-related Genes in Circulating Tumor Cells Population.

Lyberopoulou A, Galanopoulos M, Aravantinos G, Theodoropoulos GE, Marinos E, Efstathopoulos EP, Gazouli M.

Anticancer Res. 2017 Mar;37(3):1105-1112.

PMID:
28314271
4.

TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.

Fountzilas G, Giannoulatou E, Alexopoulou Z, Zagouri F, Timotheadou E, Papadopoulou K, Lakis S, Bobos M, Poulios C, Sotiropoulou M, Lyberopoulou A, Gogas H, Pentheroudakis G, Pectasides D, Koutras A, Christodoulou C, Papandreou C, Samantas E, Papakostas P, Kosmidis P, Bafaloukos D, Karanikiotis C, Dimopoulos MA, Kotoula V.

Oncotarget. 2016 May 31;7(22):32731-53. doi: 10.18632/oncotarget.9022.

5.

Low Serum Hepcidin in Patients with Autoimmune Liver Diseases.

Lyberopoulou A, Chachami G, Gatselis NK, Kyratzopoulou E, Saitis A, Gabeta S, Eliades P, Paraskeva E, Zachou K, Koukoulis GK, Mamalaki A, Dalekos GN, Simos G.

PLoS One. 2015 Aug 13;10(8):e0135486. doi: 10.1371/journal.pone.0135486. eCollection 2015.

6.

Evaluation of two highly-multiplexed custom panels for massively parallel semiconductor sequencing on paraffin DNA.

Kotoula V, Lyberopoulou A, Papadopoulou K, Charalambous E, Alexopoulou Z, Gakou C, Lakis S, Tsolaki E, Lilakos K, Fountzilas G.

PLoS One. 2015 Jun 3;10(6):e0128818. doi: 10.1371/journal.pone.0128818. eCollection 2015.

7.

Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue.

Lyberopoulou A, Aravantinos G, Efstathopoulos EP, Nikiteas N, Bouziotis P, Isaakidou A, Papalois A, Marinos E, Gazouli M.

PLoS One. 2015 Apr 22;10(4):e0123902. doi: 10.1371/journal.pone.0123902. eCollection 2015.

8.

Quantum dots-bevacizumab complexes for in vivo imaging of tumors.

Gazouli M, Bouziotis P, Lyberopoulou A, Ikonomopoulos J, Papalois A, Anagnou NP, Efstathopoulos EP.

In Vivo. 2014 Nov-Dec;28(6):1091-5.

PMID:
25398804
9.

An association study between hypoxia inducible factor-1alpha (HIF-1α) polymorphisms and osteonecrosis.

Chachami G, Kalousi A, Papatheodorou L, Lyberopoulou A, Nasikas V, Tanimoto K, Simos G, Malizos KN, Georgatsou E.

PLoS One. 2013 Nov 18;8(11):e79647. doi: 10.1371/journal.pone.0079647. eCollection 2013.

10.

Oxygen-dependent secretion of a bioactive hepcidin-GFP chimera.

Chachami G, Lyberopoulou A, Kalousi A, Paraskeva E, Pantopoulos K, Simos G.

Biochem Biophys Res Commun. 2013 Jun 14;435(4):540-5. doi: 10.1016/j.bbrc.2013.04.085. Epub 2013 May 8.

PMID:
23665013
11.

MgcRacGAP, a cytoskeleton regulator, inhibits HIF-1 transcriptional activity by blocking its dimerization.

Lyberopoulou A, Mylonis I, Papachristos G, Sagris D, Kalousi A, Befani C, Liakos P, Simos G, Georgatsou E.

Biochim Biophys Acta. 2013 Jun;1833(6):1378-87. doi: 10.1016/j.bbamcr.2013.02.025. Epub 2013 Feb 28.

12.

Development of a quantum-dot-labelled magnetic immunoassay method for circulating colorectal cancer cell detection.

Gazouli M, Lyberopoulou A, Pericleous P, Rizos S, Aravantinos G, Nikiteas N, Anagnou NP, Efstathopoulos EP.

World J Gastroenterol. 2012 Aug 28;18(32):4419-26. doi: 10.3748/wjg.v18.i32.4419.

13.

Expression of microRNAs in patients with pancreatic cancer and its prognostic significance.

Papaconstantinou IG, Manta A, Gazouli M, Lyberopoulou A, Lykoudis PM, Polymeneas G, Voros D.

Pancreas. 2013 Jan;42(1):67-71. doi: 10.1097/MPA.0b013e3182592ba7.

PMID:
22850622
14.

Quantum dots hold promise for early cancer imaging and detection.

Pericleous P, Gazouli M, Lyberopoulou A, Rizos S, Nikiteas N, Efstathopoulos EP.

Int J Cancer. 2012 Aug 1;131(3):519-28. doi: 10.1002/ijc.27528. Epub 2012 Mar 29. Review. Erratum in: Int J Cancer. 2015 Jul 1;137(1):1.

15.

Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance.

Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, Voros D.

Mol Carcinog. 2013 Apr;52(4):297-303. doi: 10.1002/mc.21864. Epub 2011 Dec 27.

PMID:
22213236
16.

MgcRacGAP interacts with HIF-1alpha and regulates its transcriptional activity.

Lyberopoulou A, Venieris E, Mylonis I, Chachami G, Pappas I, Simos G, Bonanou S, Georgatsou E.

Cell Physiol Biochem. 2007;20(6):995-1006.

Supplemental Content

Loading ...
Support Center